TXNIP and cancer: As we identified that TXNIP was a target of MAGI2-AS3 and results in the reduced expression in of TXNIP in HCC and impaired cancer progression, we suspected that altered MAGI2-AS3 expression may also cause changes in the immune cell populations in the microenvironment of HCC patients.